First Horizon Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Buy |
187
+63
| +51% | +$20.5K | ﹤0.01% | 897 |
|
|
2025
Q1 | $33.5K | Hold |
124
| – | – | ﹤0.01% | 1109 |
|
|
2024
Q4 | $29.2K | Buy |
124
+29
| +31% | +$6.82K | ﹤0.01% | 1189 |
|
|
2024
Q3 | $26.1K | Buy |
95
+8
| +9% | +$2.2K | ﹤0.01% | 1258 |
|
|
2024
Q2 | $21.1K | Sell |
87
-1
| -1% | -$243 | ﹤0.01% | 1252 |
|
|
2024
Q1 | $13.2K | Hold |
88
| – | – | ﹤0.01% | 1488 |
|
|
2023
Q4 | $16.8K | Hold |
88
| – | – | ﹤0.01% | 1393 |
|
|
2023
Q3 | $15.6K | Sell |
88
-7
| -7% | -$1.24K | ﹤0.01% | 1336 |
|
|
2023
Q2 | $18K | Sell |
95
-4
| -4% | -$760 | ﹤0.01% | 1312 |
|
|
2023
Q1 | $19.8K | Sell |
99
-5
| -5% | -$1K | ﹤0.01% | 1271 |
|
|
2022
Q4 | $24.7K | Sell |
104
-7
| -6% | -$1.66K | ﹤0.01% | 1182 |
|
|
2022
Q3 | $21K | Sell |
111
-19
| -15% | -$3.6K | ﹤0.01% | 1211 |
|
|
2022
Q2 | $18K | Buy |
130
+49
| +60% | +$6.79K | ﹤0.01% | 1331 |
|
|
2022
Q1 | $13K | Buy |
81
+12
| +17% | +$1.93K | ﹤0.01% | 1010 |
|
|
2021
Q4 | $10K | Buy |
69
+13
| +23% | +$1.88K | ﹤0.01% | 1508 |
|
|
2021
Q3 | $10K | Buy |
56
+40
| +250% | +$7.14K | ﹤0.01% | 1520 |
|
|
2021
Q2 | $2K | Sell |
16
-7
| -30% | -$875 | ﹤0.01% | 1728 |
|
|
2021
Q1 | $3K | Hold |
23
| – | – | ﹤0.01% | 1545 |
|
|
2020
Q4 | $2K | Buy |
23
+7
| +44% | +$609 | ﹤0.01% | 1300 |
|
|
2020
Q3 | $2K | Sell |
16
-66
| -80% | -$8.25K | ﹤0.01% | 1294 |
|
|
2020
Q2 | $12K | Sell |
82
-21
| -20% | -$3.07K | ﹤0.01% | 950 |
|
|
2020
Q1 | $11K | Buy |
+103
| New | +$11K | ﹤0.01% | 907 |
|
|
2019
Q2 | – | Sell |
-16
| Closed | -$1K | – | 1546 |
|
|
2019
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1464 |
|